Avient Corporation
NYSE:AVNTChemicals - Specialty
+$0.04 today
- Market cap
- $4.07B
- Beta
- 1.30
- P/E (TTM)
- 21.4
- EPS (TTM)
- $1.72
- Dividend yield
- 2.97%
Volume 0.55M
Average 0.74M
AVNT Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Avient CorporationNYSE: AVNT
Accounts Payables · Q3 FY2026 · quarter ended Sep 2026
Accounts payables dips below year-ago levels
Q3 FY2026 accounts payables of $34.5M (cash outflow) fell 23.2% year over year, behind the +234.4% change in trailing-twelve-month accounts payables.
Context
- Accounts payables amounted to 0.8% of revenue in FY2025, up 0.8 pp from a year earlier.
- Accounts payables increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -23.2% toward the trailing-twelve-month pace of +234.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- (27.6M) USD
- Year-over-year change
- -9300.0%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (27.6M) | -9300.0% |
| FY2024 | 2024-12-31 | 300K | +101.4% |
| FY2023 | 2023-12-31 | (22.2M) | -307.5% |
| FY2022 | 2022-12-31 | 10.7M | -88.8% |
| FY2021 | 2021-12-31 | 95.3M | — |
Accounts Payables vs competitors
How AVNT compares with its peers on the latest reported figures
- AVNT's LTM Sep 2026 accounts payables of $50.4M is the 4th largest of the 11 companies compared; the peer median is $19.56M.
- Its year-over-year change of +234.4% is the 4th highest of 9, against a peer median of +173.0%.
- Accounts payables amounts to 1.5% of revenue for AVNT, versus a peer median of 1.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $119M | +988.1% | — | 1.8% | |
| LTM Aug 2026 | $81.22M | +394.8% | +19.0% | 2.3% | |
| LTM Sep 2026 | $60.8M | +208.8% | — | 2.0% | |
| LTM Sep 2026 | $50.4M | +234.4% | — | 1.5% | |
| LTM Jun 2026 | $28M | +137.3% | — | 0.8% | |
| LTM Jun 2026 | $24.26M | +71.6% | — | 1.4% | |
| LTM Sep 2026 | $14.85M | +441.3% | -20.4% | 1.3% | |
| LTM Aug 2026 | $4.95M | +69.7% | — | 0.7% | |
| LTM Jun 2026 | $1.21M | -88.9% | -13.7% | 0.2% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AVNT) | $19.56M | +173.0% | -13.7% | 1.0% | |
Competitors are the stored peer set for AVNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 230.6M | 703.4M | 76.2M | 170.7M | 83.6M |
| Depreciation & Amortization | 145.9M | 163.1M | 188.8M | 179.7M | 185.9M |
| Deferred Income Tax | (27.3M) | 500K | (61.3M) | (23.8M) | (45.4M) |
| Stock-Based Compensation | 11.2M | 13.2M | 13.2M | 15.4M | 9.1M |
| Change in Working Capital | (128.1M) | 36.7M | 88.8M | (51.2M) | (3.2M) |
| Accounts Receivables | (143.1M) | 32.6M | 38.6M | (15.2M) | (18.3M) |
| Inventory | (141M) | 14M | 24.3M | (13.7M) | 600K |
| Accounts Payables | 95.3M | 10.7M | (22.2M) | 300K | (27.6M) |
| Other Working Capital | 60.7M | (20.6M) | 48.1M | (22.6M) | 42.1M |
| Other Non-Cash Items | 1.5M | (518.5M) | (104.1M) | (34M) | 71.6M |
| Operating Cash Flow | 233.8M | 398.4M | 201.6M | 256.8M | 301.6M |
| Capital Expenditures | (100.6M) | (105.5M) | (119.4M) | (121.9M) | (106.6M) |
| Acquisitions (Net) | (47.6M) | (497.9M) | 7.3M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (2M) | 99.4M | 17.9M | 1.3M | 9.6M |
| Investing Cash Flow | (150.2M) | (504M) | (94.2M) | (120.6M) | (97M) |
| Debt Repayment | (18.5M) | 343.2M | (105.8M) | (10.9M) | (150.3M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (4.2M) | (36.4M) | (3.4M) | (6.4M) | (4.1M) |
| Dividends Paid | (77.7M) | (86.8M) | (90.2M) | (94M) | (98.8M) |
| Other Financing Activities | (14.2M) | (53.6M) | (2.3M) | (9.6M) | (3.9M) |
| Financing Cash Flow | (114.6M) | 166.4M | (201.7M) | (120.9M) | (257.1M) |
| Effect of Forex Changes | (17.3M) | (20.9M) | (1M) | (16.6M) | 18.5M |
| Net Change in Cash | (48.3M) | 39.9M | (95.3M) | (1.3M) | (34M) |
| Free Cash Flow | 133.2M | 292.9M | 82.2M | 134.9M | 195M |
Avient Corporation
NYSE:AVNT
Intrinsic Alpha fair value
Locked
Current Price
$44.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.